PET imaging of mGluR5 in Alzheimer’s disease

被引：0

作者：

Adam P. Mecca

Julia W. McDonald

Hannah R. Michalak

Tyler A. Godek

Joanna E. Harris

Erika A. Pugh

Emily C. Kemp

Ming-Kai Chen

Arash Salardini

Nabeel B. Nabulsi

Keunpoong Lim

Yiyun Huang

Richard E. Carson

Stephen M. Strittmatter

Christopher H. van Dyck

机构：

[1] Yale University School of Medicine,Alzheimer’s Disease Research Unit

[2] Yale University School of Medicine,Department of Psychiatry

[3] Yale University School of Medicine,Department of Neuroscience

[4] Yale University School of Medicine,Department of Neurology

[5] Yale University School of Medicine,Department of Radiology and Biomedical Imaging

[6] Yale University School of Medicine,CNNR Program

来源：

Alzheimer's Research & Therapy | / 12卷

关键词：

mGluR5; Glutamate receptor; Alzheimer’s disease; [; F]FPEB; PET;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] A SYNAPTOTOXIC PATHWAY FROM Aβ OLIGOMER TO PRION PROTEIN TO MGLUR5 TO F KINASE IN ALZHEIMER'S DISEASE
Strittmatter, Stephen
Kostylev, M.
Kaufman, A. C.
Haas, L.
Heiss, J. K.
Gunther, E. C.
Nygaard, H. B.
NEUROBIOLOGY OF AGING, 2014, 35 : S21 - S21
[22] Evaluation of mGluR5 in Early Parkinson and Huntington Disease Using 18F-FPEB PET Imaging
Jennings, Donna
Marek, Kenneth
Russell, David
Batis, Jeff
Koren, Andre
Barret, Olivier
Tamagnan, Gilles
Seibyl, John
NEUROLOGY, 2010, 74 (09) : A413 - A414
[23] A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease
Quaglio Bellozi, Paula Maria
Gomes, Giovanni Freitas
Machado da Silva, Maria Carolina
de Assis Lima, Isabel Vieira
Alvares Batista, Carla Ribeiro
Carneiro Junior, Wellerson de Oliveira
Doria, Juliana Guimaraes
Marciano Vieira, Erica Leandro
Vieira, Rafael Pinto
de Freitas, Rossimiriam Pereira
Ferreira, Claudia Natalia
Candelario-Jalil, Eduardo
Wyss-Coray, Tony
Ribeiro, Fabfola Mara
Pinheiro de Oliveira, Antonio Carlos
NEUROPHARMACOLOGY, 2019, 160
[24] 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease
Kang, Yeona
Henchcliffe, Claire
Verma, Ajay
Vallabhajosula, Shankar
He, Bin
Kothari, Paresh J.
Pryor, Kane O.
Mozley, P. David
JOURNAL OF NEUROIMAGING, 2019, 29 (01) : 97 - 103
[25] Autism, Alzheimer disease, and fragile X APP, FMRP, and mGluR5 are molecular links
Sokol, D. K.
Maloney, B.
Long, J. M.
Ray, B.
Lahiri, D. K.
NEUROLOGY, 2011, 76 (15) : 1344 - 1352
[26] Microdose PET for the metabotropic glutamate receptor type 5 (mGluR5)
Brasic, James
Mishra, Chakradhar
Mathur, Anil
Sweeney, Kristie
Folsom, Timothy
Kitzmiller, Kelly
Mellinger-Pilgrim, Rebecca
Wong, Dean
Fatemi, S.
JOURNAL OF NUCLEAR MEDICINE, 2018, 59
[27] 18F-FPEB PET Imaging Targeting the mGluR5 Receptor in Neurodegenerative Disorders
Jennings, D.
Seibyl, J.
Barret, O.
Tamagnan, G.
Batis, J.
Alagille, D.
Baldwin, R.
Zubal, G.
Russell, D.
Marek, K.
CURRENT NEUROPHARMACOLOGY, 2011, 9 : 30 - 30
[28] Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models
Abd-Elrahman, Khaled S.
Hamilton, Alison
Vasefi, Maryam
Ferguson, Stephen S. G.
MOLECULAR BRAIN, 2018, 11
[29] Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer’s disease: A [18F]PSS232 PET/MRI study
Jie Wang
Yingfang He
Xing Chen
Lin Huang
Junpeng Li
Zhiwen You
Qi Huang
Shuhua Ren
Kun He
Roger Schibli
Linjing Mu
Yihui Guan
Qihao Guo
Jun Zhao
Fang Xie
Alzheimer's Research & Therapy, 16
[30] Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [18F]PSS232 PET/MRI study
Wang, Jie
He, Yingfang
Chen, Xing
Huang, Lin
Li, Junpeng
You, Zhiwen
Huang, Qi
Ren, Shuhua
He, Kun
Schibli, Roger
Mu, Linjing
Guan, Yihui
Guo, Qihao
Zhao, Jun
Xie, Fang
ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)

← 1 2 3 4 5 →